Novel agents for neurological disorders described in recent AstraZeneca and Merck Frosst patents April 24, 2008
Motor improvement with pardoprunox in patients with early-stage PD seen in phase II trial April 23, 2008
Alseres opens seven enrollment sites for first stage of Altropane phase III clinical trial program April 22, 2008
RSS